271 related articles for article (PubMed ID: 19059294)
1. Phenotypic and genetic diversity of the traditional Lister smallpox vaccine.
Garcel A; Perino J; Crance JM; Drillien R; Garin D; Favier AL
Vaccine; 2009 Jan; 27(5):708-17. PubMed ID: 19059294
[TBL] [Abstract][Full Text] [Related]
2. Postexposure immunization with modified vaccinia virus Ankara or conventional Lister vaccine provides solid protection in a murine model of human smallpox.
Paran N; Suezer Y; Lustig S; Israely T; Schwantes A; Melamed S; Katz L; Preuss T; Hanschmann KM; Kalinke U; Erez N; Levin R; Velan B; Löwer J; Shafferman A; Sutter G
J Infect Dis; 2009 Jan; 199(1):39-48. PubMed ID: 19012492
[TBL] [Abstract][Full Text] [Related]
3. Vaccinia virus-induced smallpox postvaccinal encephalitis in case of blood-brain barrier damage.
Garcel A; Fauquette W; Dehouck MP; Crance JM; Favier AL
Vaccine; 2012 Feb; 30(7):1397-405. PubMed ID: 22227123
[TBL] [Abstract][Full Text] [Related]
4. Safety, immunogenicity and protective efficacy in mice of a new cell-cultured Lister smallpox vaccine candidate.
Ferrier-Rembert A; Drillien R; Meignier B; Garin D; Crance JM
Vaccine; 2007 Nov; 25(49):8290-7. PubMed ID: 17964011
[TBL] [Abstract][Full Text] [Related]
5. Genomic differences of Vaccinia virus clones from Dryvax smallpox vaccine: the Dryvax-like ACAM2000 and the mouse neurovirulent Clone-3.
Osborne JD; Da Silva M; Frace AM; Sammons SA; Olsen-Rasmussen M; Upton C; Buller RM; Chen N; Feng Z; Roper RL; Liu J; Pougatcheva S; Chen W; Wohlhueter RM; Esposito JJ
Vaccine; 2007 Dec; 25(52):8807-32. PubMed ID: 18037545
[TBL] [Abstract][Full Text] [Related]
6. Comparative efficacy of modified vaccinia Ankara (MVA) as a potential replacement smallpox vaccine.
Phelps AL; Gates AJ; Hillier M; Eastaugh L; Ulaeto DO
Vaccine; 2007 Jan; 25(1):34-42. PubMed ID: 16950548
[TBL] [Abstract][Full Text] [Related]
7. Comparative efficacy of replicating smallpox vaccine strains in a murine challenge model.
Phelps A; Gates AJ; Hillier M; Eastaugh L; Ulaeto DO
Vaccine; 2005 May; 23(27):3500-7. PubMed ID: 15855008
[TBL] [Abstract][Full Text] [Related]
8. Characterization of a vaccinia virus strain used to produce smallpox vaccine in Argentina between 1937 and 1970.
Lewis A; Bok K; Perez O; DeFillippo J; Paolazzi C; Gomez JA
Arch Virol; 2005 Jul; 150(7):1485-91. PubMed ID: 15750861
[TBL] [Abstract][Full Text] [Related]
9. Host range, growth property, and virulence of the smallpox vaccine: vaccinia virus Tian Tan strain.
Fang Q; Yang L; Zhu W; Liu L; Wang H; Yu W; Xiao G; Tien P; Zhang L; Chen Z
Virology; 2005 May; 335(2):242-51. PubMed ID: 15840523
[TBL] [Abstract][Full Text] [Related]
10. Genomic sequence of a clonal isolate of the vaccinia virus Lister strain employed for smallpox vaccination in France and its comparison to other orthopoxviruses.
Garcel A; Crance JM; Drillien R; Garin D; Favier AL
J Gen Virol; 2007 Jul; 88(Pt 7):1906-1916. PubMed ID: 17554021
[TBL] [Abstract][Full Text] [Related]
11. The nonreplicating smallpox candidate vaccines defective vaccinia Lister (dVV-L) and modified vaccinia Ankara (MVA) elicit robust long-term protection.
Coulibaly S; Brühl P; Mayrhofer J; Schmid K; Gerencer M; Falkner FG
Virology; 2005 Oct; 341(1):91-101. PubMed ID: 16061267
[TBL] [Abstract][Full Text] [Related]
12. Microarray assay for evaluation of the genetic stability of modified vaccinia virus Ankara B5R gene.
Laassri M; Meseda CA; Williams O; Merchlinsky M; Weir JP; Chumakov K
J Med Virol; 2007 Jun; 79(6):791-802. PubMed ID: 17457926
[TBL] [Abstract][Full Text] [Related]
13. Protection induced in mice against a lethal orthopox virus by the Lister strain of vaccinia virus and modified vaccinia virus Ankara (MVA).
Abdalrhman I; Gurt I; Katz E
Vaccine; 2006 May; 24(19):4152-60. PubMed ID: 16603280
[TBL] [Abstract][Full Text] [Related]
14. Genomic sequence and virulence of clonal isolates of vaccinia virus Tiantan, the Chinese smallpox vaccine strain.
Zhang Q; Tian M; Feng Y; Zhao K; Xu J; Liu Y; Shao Y
PLoS One; 2013; 8(4):e60557. PubMed ID: 23593246
[TBL] [Abstract][Full Text] [Related]
15. Genomic Analysis, Phenotype, and Virulence of the Historical Brazilian Smallpox Vaccine Strain IOC: Implications for the Origins and Evolutionary Relationships of Vaccinia Virus.
Medaglia ML; Moussatché N; Nitsche A; Dabrowski PW; Li Y; Damon IK; Lucas CG; Arruda LB; Damaso CR
J Virol; 2015 Dec; 89(23):11909-25. PubMed ID: 26378174
[TBL] [Abstract][Full Text] [Related]
16. Mouse neurotoxicity test for vaccinia-based smallpox vaccines.
Li Z; Rubin SA; Taffs RE; Merchlinsky M; Ye Z; Carbone KM
Vaccine; 2004 Mar; 22(11-12):1486-93. PubMed ID: 15063573
[TBL] [Abstract][Full Text] [Related]
17. An attenuated LC16m8 smallpox vaccine: analysis of full-genome sequence and induction of immune protection.
Morikawa S; Sakiyama T; Hasegawa H; Saijo M; Maeda A; Kurane I; Maeno G; Kimura J; Hirama C; Yoshida T; Asahi-Ozaki Y; Sata T; Kurata T; Kojima A
J Virol; 2005 Sep; 79(18):11873-91. PubMed ID: 16140764
[TBL] [Abstract][Full Text] [Related]
18. Short- and long-term immunogenicity and protection induced by non-replicating smallpox vaccine candidates in mice and comparison with the traditional 1st generation vaccine.
Ferrier-Rembert A; Drillien R; Tournier JN; Garin D; Crance JM
Vaccine; 2008 Mar; 26(14):1794-804. PubMed ID: 18336966
[TBL] [Abstract][Full Text] [Related]
19. Attenuation of a vaccine strain of vaccinia virus via inactivation of interferon viroceptor.
Dénes B; Gridley DS; Fodor N; Takátsy Z; Timiryasova TM; Fodor I
J Gene Med; 2006 Jul; 8(7):814-23. PubMed ID: 16634110
[TBL] [Abstract][Full Text] [Related]
20. Capturing the natural diversity of the human antibody response against vaccinia virus.
Lantto J; Haahr Hansen M; Rasmussen SK; Steinaa L; Poulsen TR; Duggan J; Dennis M; Naylor I; Easterbrook L; Bregenholt S; Haurum J; Jensen A
J Virol; 2011 Feb; 85(4):1820-33. PubMed ID: 21147924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
